All In Biotech

Drug Trial Radar · NCT00320099

Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

Phase 3 Study of Corticotherapy (Hydrocortisone Alone Versus Hydrocortisone Plus Fludrocortisone) Versus Corticotherapy Plus Intensive Insulin Therapy for Septic Shock

Last checked: Nov 20, 2026Latest source record: Apr 6, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 508 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

508

Actual

Start

Jan 2006

Primary completion

Jan 2009

Study completion Feb 2009

Sponsor

Lead sponsor
University of VersaillesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Assistance Publique - Hôpitaux de Paris
First posted
May 3, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare, in adults with septic shock, the safety and efficacy of a combination of moderate doses of corticosteroids and intensive insulin therapy to that of moderate doses of corticosteroids. In addition, this study will compare the efficacy and safety of hydrocortisone alone versus hydrocortisone plus fludrocortisone

Conditions

  • Septic Shock

Interventions

  • recombinant human insulinDrug

    intensive insulin therapy as a continuous infusion to maintain blood glucose levels between 4 and 6 mmol/l

  • hydrocortisoneDrug

    50 mg as iv bolus every 6 hours for 7 days

  • fludrocortisoneDrug

    50 µg once a day via a nasogastric tube for seven days

  • HydrocortisoneDrug

    hydrocortisone 50mg q6 for 7 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. In-hospital mortalityTime frame: Day 180

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Hôpital Avicenne

    Bobigny, France

  • Hôpital Jean Verdier

    Bondy, France

  • CHU Grenoble

    Grenoble, France

  • Hôpital central

    Nancy, France

  • Hôpital Saint Louis

    Paris, France

  • Hôpital Bichat Claude Bernard

    Paris, France

  • hôpital Cochin

    Paris, France

  • Hôpital Delafontaine

    Saint-Denis, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.